基本信息
views: 191

Bio
1995,6-1998,6南开大学生物系,理学博士学位;1998,6-2000,12中国协和医科大学医学分子生物学国家重点实验室,博士后。近年来主持与参加的国家级、天津市及院级科研课题多项,在美国国家生物技术信息中心Genbank注册2个新基因cDNA全长。2003年、2005年、2011年获武警部队科技进步二等奖2项、三等奖1项。2006年荣获全军院校育才银奖;现主持和参加国家自然科学基金面上项目两项,发表论文20余篇。主编并参编教学参考书3部,执笔10万余字。主要研究方向:心脑血管疾病相关基因及分子机制的研究。本研究方向重点以新克隆的人ZNF580及大鼠、小鼠ZFP580为切入点,围绕AS心脑血管疾病及支架术后再狭窄的发病机制和防治措施开展基础研究。
Research Interests
Papers共 147 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Clinical Oncologyno. 4_suppl (2025)
Strahlentherapie und Onkologiepp.1-13, (2025)
BMC Cancerno. 1 (2025): 1-11
Journal of Translational Medicineno. 1 (2024): 1-11
Liang Yi, Qifeng Wang,Qingwu Du,Cihui Yan, Yaowen Zhang, WENBIN SHEN, Xiaolin Ge,Ning Yang,Xiujun Su,Feng Wang,Jian Zhang,Zhiyong Yuan,Wei Huang,WENCHENG ZHANG
crossref(2024)
Hui Huang, Gang Zhao, Tierun Wang, Yi You,Tian Zhang,Xi Chen,Jie Dong, Lei Gong,Xiaobin Shang,Fuliang Cao,Peng Tang,Hongjing Jiang, Pin Wang, Qinsong Pang,Cihui Yan,Wencheng Zhang
CANCER LETTERS (2024)
Expert opinion on biological therapyno. 11 (2024): 1221-1232
Jiacheng Li, Xiaofeng Wang, Jianzhong Cao, Chengcheng Fan,Qin Xiao, Zhunhao Zheng, Wenyan Gao, Xiao Liu, Peixin Feng, Fang Liu,Shuyu Ouyang, Tian Zhang, Xi Chen,Zhiyong Yuan,Qingsong Pang,Ping Wang, Qifeng Wang,Wencheng Zhang
Cancer letters (2024): 217411-217411
CANCER MEDICINEno. 15 (2024)
Rui Li, Xiaofeng Wang, Hui Bai, Wei Tian, Junxiang Luo, Yanling Wu, Yihan Xu, Jiacheng Li, Yang Dong, Minglei Yang,Guofang Zhao,Cihui Yan,WENCHENG ZHANG,Zhiyong Yuan
crossref(2024)
Load More
Author Statistics
#Papers: 147
#Citation: 1114
H-Index: 18
G-Index: 30
Sociability: 6
Diversity: 3
Activity: 5
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn